Predicting Stroke Recurrence with Lp-PLA2 and Lp(a)
Author Information
Author(s): Feng Yu, Shenyang Zhang, Hailiang Li, Hao Li, Ruiguo Dong, Shiguang Zhu, Yanlong Zhou
Primary Institution: Affiliated Hospital of Xuzhou Medical University
Hypothesis
Is the combination of Lp-PLA2 and Lp(a) a better biomarker for predicting recurrent stroke risk in patients with acute ischemic stroke?
Conclusion
The study suggests that using Lp-PLA2 and Lp(a) together can more accurately predict the risk of stroke recurrence in patients with acute ischemic stroke.
Supporting Evidence
- 101 out of 580 patients experienced stroke recurrence within two years.
- Age, diabetes, Lp-PLA2, and Lp(a) were identified as independent risk factors for stroke recurrence.
- The combination of Lp-PLA2 and Lp(a) showed superior predictive efficacy for long-term stroke recurrence risk.
Takeaway
Doctors can use two blood tests, Lp-PLA2 and Lp(a), to better predict if someone will have another stroke after their first one.
Methodology
The study included 580 patients with acute ischemic stroke, measuring Lp-PLA2 and Lp(a) levels at admission and monitoring for stroke recurrence over two years.
Limitations
The study only measured Lp-PLA2 and Lp(a) levels at one point in time and did not track changes over the disease progression.
Participant Demographics
Median age of participants was 62 years, with 61.39% being male.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 0.678–0.783
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website